Expertise in
1
conditions

Dr. Mark E. Reeves

General Surgery
Loma Linda University Faculty Medical Clinics-Ear Nose And Throat Surgery
11370 Anderson St Ste 2100, 
Loma Linda, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Loma Linda University Faculty Medical Clinics-Ear Nose And Throat Surgery
11370 Anderson St Ste 2100, 
Loma Linda, CA 

Overview

Mark Reeves is a General Surgeon practicing medicine in Loma Linda, California.

Dr. Reeves is highly rated in 1 condition, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Congenital Generalized Fibromatosis, Desmoid Tumor, Pancreaticoduodenectomy, and Gastrectomy.

He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 6 clinical trials.

Specialties

General Surgery

Licenses

Surgery in CA

Hospital Affiliations

Loma Linda University Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

Loma Linda University Faculty Medical Clinics-Ear Nose And Throat Surgery
11370 Anderson St Ste 2100, Loma Linda, CA 92354
Other Locations
Loma Linda Univ Anesthesiology Medical Group Inc
11234 Anderson St, Loma Linda, CA 92350

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Drug, Biological, Procedure
Study Drugs: Bendamustine Hydrochloride, Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Obinutuzumab, Prednisone, Umbralisib, Vincristine Sulfate
Study Phase: Phase 2
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Enrollment Status: Terminated
Publish Date: July 27, 2022
Intervention Type: Drug, Other
Study Drug: Varenicline
Study Phase: Phase 3
View 5 Less Clinical Trials

74 Total Publications

Exploratory study of a long-term hospital-based cervical cancer screening program in a high HIV prevalence area of rural Malawi.
Exploratory study of a long-term hospital-based cervical cancer screening program in a high HIV prevalence area of rural Malawi.
Journal: Gynecologic oncology reports
Published: September 03, 2025
Similar Doctors
Expertise in
16
conditions
Dr. Alfred A. Simental
General Surgery
Expertise in
16
conditions
Dr. Alfred A. Simental
General Surgery
Referral may be required

Loma Linda Univ Anesthesiology Medical Group Inc

11234 Anderson St, 
Loma Linda, CA 
 (0.3 miles away)
909-558-2824
Languages Spoken:
English
See accepted insurances

Alfred Simental is a General Surgeon practicing medicine in Loma Linda, California. Dr. Simental is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Anaplastic Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Expertise in
20
conditions
Dr. John C. Lipham
General Surgery
Expertise in
20
conditions
Dr. John C. Lipham
General Surgery
Referral may be required

Los Angeles-Plastic Surgery

1450 San Pablo St Ste 6200, 
Los Angeles, CA 
 (54.4 miles away)
323-442-6868
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Lipham is a General Surgeon practicing medicine in Los Angeles, California. Dr. Lipham is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Hiatal Hernia, Hernia, Endoscopy, and Gastrectomy.

Expertise in
17
conditions
Dr. Ahmed M. Abou-Zamzam
General Surgery
Expertise in
17
conditions
Dr. Ahmed M. Abou-Zamzam
General Surgery
Referral may be required

Loma Linda University Faculty Medical Clinics-Ear Nose And Throat Surgery

11370 Anderson St Ste 2100, 
Loma Linda, CA 
 (0.1 miles away)
909-558-2840
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ahmed Abou-Zamzam is a General Surgeon practicing medicine in Loma Linda, California. Dr. Abou-Zamzam is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Carotid Artery Disease, Peripheral Artery Disease, Arterial Embolism, Aneurysm Repair, and Carotid Artery Surgery.

Frequently Asked Questions about Dr. Mark E. Reeves

How do I make an appointment with Dr. Mark E. Reeves?

You can book an appointment with Dr. Mark E. Reeves by calling their office at 909-558-2822. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark E. Reeves a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark E. Reeves is classified as an Advanced expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark E. Reeves specialize in?

While Dr. Mark E. Reeves is a General Surgery, they have specific expertise in Familial Colorectal Cancer, Pancreaticoduodenectomy, and Congenital Generalized Fibromatosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Mark E. Reeves participate in research or clinical trials?

Yes. Dr. Mark E. Reeves has published 74 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Mark E. Reeves's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark E. Reeves accept my insurance?

Dr. Mark E. Reeves accepts most major insurance plans, including Anthem BCBS and Humana. We recommend calling the office directly at 909-558-2822 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reeves's expertise for a condition
ConditionClose
      View All 41 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile